194 related articles for article (PubMed ID: 26673327)
1. The Msi Family of RNA-Binding Proteins Function Redundantly as Intestinal Oncoproteins.
Li N; Yousefi M; Nakauka-Ddamba A; Li F; Vandivier L; Parada K; Woo DH; Wang S; Naqvi AS; Rao S; Tobias J; Cedeno RJ; Minuesa G; Y K; Barlowe TS; Valvezan A; Shankar S; Deering RP; Klein PS; Jensen ST; Kharas MG; Gregory BD; Yu Z; Lengner CJ
Cell Rep; 2015 Dec; 13(11):2440-2455. PubMed ID: 26673327
[TBL] [Abstract][Full Text] [Related]
2. Transformation of the intestinal epithelium by the MSI2 RNA-binding protein.
Wang S; Li N; Yousefi M; Nakauka-Ddamba A; Li F; Parada K; Rao S; Minuesa G; Katz Y; Gregory BD; Kharas MG; Yu Z; Lengner CJ
Nat Commun; 2015 Mar; 6():6517. PubMed ID: 25774828
[TBL] [Abstract][Full Text] [Related]
3. mTOR complex 2 is required for the development of prostate cancer induced by Pten loss in mice.
Guertin DA; Stevens DM; Saitoh M; Kinkel S; Crosby K; Sheen JH; Mullholland DJ; Magnuson MA; Wu H; Sabatini DM
Cancer Cell; 2009 Feb; 15(2):148-59. PubMed ID: 19185849
[TBL] [Abstract][Full Text] [Related]
4. Deciphering the Role of Intestinal Crypt Cell Populations in Resistance to Chemotherapy.
Frau C; Jamard C; Delpouve G; Guardia GDA; Machon C; Pilati C; Nevé CL; Laurent-Puig P; Guitton J; Galante PAF; Penalva LO; Freund JN; de la Fouchardiere C; Plateroti M
Cancer Res; 2021 May; 81(10):2730-2744. PubMed ID: 33741693
[TBL] [Abstract][Full Text] [Related]
5. PDK1-SGK1 Signaling Sustains AKT-Independent mTORC1 Activation and Confers Resistance to PI3Kα Inhibition.
Castel P; Ellis H; Bago R; Toska E; Razavi P; Carmona FJ; Kannan S; Verma CS; Dickler M; Chandarlapaty S; Brogi E; Alessi DR; Baselga J; Scaltriti M
Cancer Cell; 2016 Aug; 30(2):229-242. PubMed ID: 27451907
[TBL] [Abstract][Full Text] [Related]
6. The Musashi proteins MSI1 and MSI2 are required for photoreceptor morphogenesis and vision in mice.
Sundar J; Matalkah F; Jeong B; Stoilov P; Ramamurthy V
J Biol Chem; 2021; 296():100048. PubMed ID: 33168629
[TBL] [Abstract][Full Text] [Related]
7. Dormant Intestinal Stem Cells Are Regulated by PTEN and Nutritional Status.
Richmond CA; Shah MS; Deary LT; Trotier DC; Thomas H; Ambruzs DM; Jiang L; Whiles BB; Rickner HD; Montgomery RK; Tovaglieri A; Carlone DL; Breault DT
Cell Rep; 2015 Dec; 13(11):2403-2411. PubMed ID: 26686631
[TBL] [Abstract][Full Text] [Related]
8. The overexpression of the putative gut stem cell marker Musashi-1 induces tumorigenesis through Wnt and Notch activation.
Rezza A; Skah S; Roche C; Nadjar J; Samarut J; Plateroti M
J Cell Sci; 2010 Oct; 123(Pt 19):3256-65. PubMed ID: 20826465
[TBL] [Abstract][Full Text] [Related]
9. Slit2/Robo1 signaling promotes intestinal tumorigenesis through Src-mediated activation of the Wnt/β-catenin pathway.
Zhang QQ; Zhou DL; Lei Y; Zheng L; Chen SX; Gou HJ; Gu QL; He XD; Lan T; Qi CL; Li JC; Ding YQ; Qiao L; Wang LJ
Oncotarget; 2015 Feb; 6(5):3123-35. PubMed ID: 25605242
[TBL] [Abstract][Full Text] [Related]
10. Livers with constitutive mTORC1 activity resist steatosis independent of feedback suppression of Akt.
Kenerson HL; Subramanian S; McIntyre R; Kazami M; Yeung RS
PLoS One; 2015; 10(2):e0117000. PubMed ID: 25646773
[TBL] [Abstract][Full Text] [Related]
11. Image-based detection and targeting of therapy resistance in pancreatic adenocarcinoma.
Fox RG; Lytle NK; Jaquish DV; Park FD; Ito T; Bajaj J; Koechlein CS; Zimdahl B; Yano M; Kopp J; Kritzik M; Sicklick J; Sander M; Grandgenett PM; Hollingsworth MA; Shibata S; Pizzo D; Valasek M; Sasik R; Scadeng M; Okano H; Kim Y; MacLeod AR; Lowy AM; Reya T
Nature; 2016 Jun; 534(7607):407-411. PubMed ID: 27281208
[TBL] [Abstract][Full Text] [Related]
12. PTEN loss and KRAS activation leads to the formation of serrated adenomas and metastatic carcinoma in the mouse intestine.
Davies EJ; Marsh Durban V; Meniel V; Williams GT; Clarke AR
J Pathol; 2014 May; 233(1):27-38. PubMed ID: 24293351
[TBL] [Abstract][Full Text] [Related]
13. RNA binding protein Musashi-1 directly targets Msi2 and Erh during early testis germ cell development and interacts with IPO5 upon translocation to the nucleus.
Sutherland JM; Sobinoff AP; Fraser BA; Redgrove KA; Davidson TL; Siddall NA; Koopman P; Hime GR; McLaughlin EA
FASEB J; 2015 Jul; 29(7):2759-68. PubMed ID: 25782991
[TBL] [Abstract][Full Text] [Related]
14. Crystal and solution structures of human oncoprotein Musashi-2 N-terminal RNA recognition motif 1.
Lan L; Xing M; Kashipathy M; Douglas J; Gao P; Battaile K; Hanzlik R; Lovell S; Xu L
Proteins; 2020 Apr; 88(4):573-583. PubMed ID: 31603583
[TBL] [Abstract][Full Text] [Related]
15. RNA-binding protein Musashi1 modulates glioma cell growth through the post-transcriptional regulation of Notch and PI3 kinase/Akt signaling pathways.
Muto J; Imai T; Ogawa D; Nishimoto Y; Okada Y; Mabuchi Y; Kawase T; Iwanami A; Mischel PS; Saya H; Yoshida K; Matsuzaki Y; Okano H
PLoS One; 2012; 7(3):e33431. PubMed ID: 22428049
[TBL] [Abstract][Full Text] [Related]
16. RNA-binding protein Musashi family: roles for CNS stem cells and a subpopulation of ependymal cells revealed by targeted disruption and antisense ablation.
Sakakibara S; Nakamura Y; Yoshida T; Shibata S; Koike M; Takano H; Ueda S; Uchiyama Y; Noda T; Okano H
Proc Natl Acad Sci U S A; 2002 Nov; 99(23):15194-9. PubMed ID: 12407178
[TBL] [Abstract][Full Text] [Related]
17. Knockdown of RNA binding protein musashi-1 leads to tumor regression in vivo.
Sureban SM; May R; George RJ; Dieckgraefe BK; McLeod HL; Ramalingam S; Bishnupuri KS; Natarajan G; Anant S; Houchen CW
Gastroenterology; 2008 May; 134(5):1448-58. PubMed ID: 18471519
[TBL] [Abstract][Full Text] [Related]
18. Dissecting the signaling pathways that mediate cancer in PTEN and LKB1 double-knockout mice.
Chen J; Zhang XD; Proud C
Sci Signal; 2015 Sep; 8(392):pe1. PubMed ID: 26329580
[TBL] [Abstract][Full Text] [Related]
19. A 1536-well fluorescence polarization assay to screen for modulators of the MUSASHI family of RNA-binding proteins.
Minuesa G; Antczak C; Shum D; Radu C; Bhinder B; Li Y; Djaballah H; Kharas MG
Comb Chem High Throughput Screen; 2014; 17(7):596-609. PubMed ID: 24912481
[TBL] [Abstract][Full Text] [Related]
20. ITF2 prevents activation of the β-catenin-TCF4 complex in colon cancer cells and levels decrease with tumor progression.
Shin HW; Choi H; So D; Kim YI; Cho K; Chung HJ; Lee KH; Chun YS; Cho CH; Kang GH; Kim WH; Park JW
Gastroenterology; 2014 Aug; 147(2):430-442.e8. PubMed ID: 24846398
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
